PharmaEssentia’s ropeg receives ET approvals in four markets
PharmaEssentia’s ropeg received approvals for ET in the US, China, Japan and Taiwan.
Related stories
Nexperia Initiates Legal Proceedings Against Wingtech and Related Parties
Nexperia says it has initiated legal proceedings in the Netherlands against Wingtech, Xuezheng Zhang and Nexperia’s Chinese entities.
L impact | REGULATION | Nov 03, 2026, 01:10 PM UTC
China Tells Major Securities Firms to Scale Back IPO Work
China has told its biggest securities firms and banks to throttle back IPO work and focus on supporting the struggling stock market, according to people familiar with the matter.
M impact | REGULATION | Nov 03, 2026, 01:02 PM UTC
Senegal Parliament Rejects Revised Budget Bill
Senegalese lawmakers voted against an amended budget bill on Tuesday, the first vice president of the National Assembly said. The revised budget is seen as crucial to securing a ne
M impact | REGULATION | Nov 03, 2026, 01:02 PM UTC
India Attaches 5.1 Billion Rupees in Assets Linked to Anil Ambani Group
India's Enforcement Directorate attached assets worth 5.1 billion rupees linked to the Reliance Anil Ambani group in bank fraud cases.
M impact | REGULATION | Nov 03, 2026, 12:51 PM UTC
India’s TRAI Releases Revised Telecom Interconnection Regulations
The regulations will take effect on January 1, 2027.
L impact | REGULATION | Nov 03, 2026, 12:48 PM UTC
Senegal Parliament Votes Against Revised Budget Bill
L impact | REGULATION | Nov 03, 2026, 12:36 PM UTC